Hubs
FTC and DOJ Workshop on Antitrust Enforcement in Pharmaceutical Industry
Client UpdatesAntitrust Update
Select Options
results
Page of
On the Interface of Intellectual Property and Antitrust: The Case of Divisional Patent Applications in the Pharmaceutical Sector
Client UpdatesAntitrust Update
What FTC Victory Means For Reverse Payment Settlements
External ArticleLaw360
Fifth Circuit Hands FTC Win in FTC’s First Fully-Litigated Reverse-Payment Case Following the Supreme Court’s Landmark Actavis Decision
Client UpdatesAntitrust Update
GCR Insight - Antimonopoly & Unilateral Conduct 2020
External ArticleGlobal Competition Review Know How: U.S. Antimonopoly & Unilateral Conduct
External ArticleFTC Issues Decision in Impax, Scrutinizes Reverse Payments Under Actavis
External ArticleThe AIPLA Antitrust News, AIPLA Committee on Antitrust Law
Reverse Payments and Beyond: Antitrust Risks for Pharmaceutical and Biotechnology Companies Amid Heightened Scrutiny of Prescription Drug Pricing
External ArticleAmerican Health Lawyers Association PG Briefing
The FDA’s and FTC’s Increased Focus on Generic Drug Competition Signals Enhanced Attention to REMS Issues
External ArticleABA’s Antitrust Health Care Chronicle
Events
Recent
results
Page of
GCR Live 7th Annual Antitrust Law Leaders Forum
Global Competition Review will host its international conference titled “GCR Live 7th Annual Antitrust Law Leaders Forum” from Friday, February 2nd to Saturday, February 3rd in Miami, Florida.